Orthofix International (Nasdaq: OFIX) reported earnings on Oct. 24. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q3), Orthofix International missed estimates on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue shrank significantly and GAAP earnings per share shrank significantly.

Gross margins grew, operating margins expanded, net margins dropped.

Revenue details
 Orthofix International logged revenue of $114.8 million. The six analysts polled by S&P Capital IQ predicted revenue of $120.5 million on the same basis. GAAP reported sales were 21% lower than the prior-year quarter's $144.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.76. The seven earnings estimates compiled by S&P Capital IQ anticipated $0.74 per share. GAAP EPS of $0.39 for Q3 were 41% lower than the prior-year quarter's $0.66 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 80.5%, 540 basis points better than the prior-year quarter. Operating margin was 19.0%, 140 basis points better than the prior-year quarter. Net margin was 6.6%, 200 basis points worse than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $127.7 million. On the bottom line, the average EPS estimate is $0.84.

Next year's average estimate for revenue is $491.9 million. The average EPS estimate is $3.05.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 119 members out of 127 rating the stock outperform, and eight members rating it underperform. Among 37 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 36 give Orthofix International a green thumbs-up, and one give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Orthofix International is outperform, with an average price target of $47.33.